Preoperative Oral Magnesium to Prevent Postoperative Atrial Fibrillation Following Coronary Surgery (POMAF-CS)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT03703349
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- St Joseph University, Beirut, Lebanon
- Registry
-
NCT03703349
-
- Other papers using this trial's data
- Preoperative oral magnesium loading to prevent postoperative atrial fibrillation following coronary surgery: a prospective randomized controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Lebanon
- Registry status
- Completed
Technical summary
Registry record NCT03703349. Randomized; quadruple masking; primary purpose prevention. Start 2018-11-24 (actual); primary completion 2019-10-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Preoperative Oral Magnesium to Prevent Postoperative Atrial Fibrillation Following Coronary Surgery (POMAF-CS)
- Acronym
- POMAF-CS
- Condition
- Atrial Fibrillation
- Condition
- Coronary Artery Disease
- Condition
- Surgery--Complications
- Intervention (Drug)
- Magnesium Sulfate
- Intervention (Drug)
- Placebo Oral Tablet
- Lead sponsor
- St Joseph University, Beirut, Lebanon
Record details
- Record id
cardio:ct-nct03703349- Content hash
e2787cad375cdba8764fa7c7c1da180957d32a225f24fdfb4dbd30106d970068